NanoRepro AG aims to steadily increase value for its customers, shareholders and employees. For this purpose, the company delivers high quality and innovative products – especially self-diagnostics – in the field of family planning and health awareness. Nano Repro is seeking long term National, European and International leadership in this sector. NanoRepro is an innovative leader in self-diagnostics. For years there has been an increasing worldwide demand and sales in the market in which we operate. For the next few years, external analysts predict further growth in this medical sector of the market. In Germany the sector of ovulation testing is growing annually by around 30% above average. The fast sales growth of rapid tests for domestic use can be explained by the following factors:
- Time and costs – self-tests are significantly less expensive and time-intensive than performing a similar test at the doctors
- Discretion – self testing ensures there is a high level of discretion, which is especially important for more intimate issues
- Health awareness – The growing health awareness among the population has a positive effect on the demand of self-tests
Innovation, quality and delivery of NanoRepro AG is ensured by a competent and experienced management and partner team. To meet the high demands of the customers, the company’s scientists work closely together with institutions such as the Fraunhofer Institute and the University of Munich. With regard to the product design and marketing, NanoRepro AG ensures maximum flexibility and a short time-to-market. An important success factor of the company lies in the continuous optimization of manufacturing costs, due to its possible value for money. By exclusivity agreements, NanoRepro AG represents an interesting business partner in the medical field.
